Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis

doi:10.13105/wjma.v4.i3.69

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9755)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

447

WORD

371

HTML

4196

Figures (1-4)

190

Tables (1-3)

228

Sum=5432

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

499

Download

966

Sum=1465

Publishing Process of This Article

Item

Count

Browse

1079

Download

1779

Sum=2858

Jun 26, 2016 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Meta-Anal. Jun 26, 2016; 4(3): 69-76
Published online Jun 26, 2016. doi: 10.13105/wjma.v4.i3.69

Full Size Figure Download Figure

Figure 2 The effects of degarelix (240/80 mg) and goserelin (3. 6 mg) on mean percentage changes of total prostate volume and quality of life related to urinary symptoms within included studies. QoL: Quality of life.

Citation: Fang C, Wu CL, Liu SS, Ge L, Bai JL. Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis. World J Meta-Anal 2016; 4(3): 69-76
URL: https://www.wjgnet.com/2308-3840/full/v4/i3/69.htm
DOI: https://dx.doi.org/10.13105/wjma.v4.i3.69